Biotech

All Articles

Orion to make use of Aitia's 'electronic twins' to find new cancer medications

.Finnish biotech Orion has spied possible in Aitia's "digital double" technology to create brand-new...

Windtree's surprise med rears blood pressure in most current phase 2 succeed

.While Windtree Rehabs has actually had a hard time to expand the economic origins required to endur...

2 cancer cells biotechs merge, generating worldwide impact

.OncoC4 is actually taking AcroImmune-- as well as its own in-house scientific manufacturing capabil...

Amgen records 1st period 3 gain for $400M dermatitis medication

.Amgen has discussed (PDF) the 1st period 3 information on its own $400 thousand dermatitis medicati...

Biogen, UCB document period 3 lupus gain after neglecting earlier trial

.Biogen as well as UCB's bank on advancing right into phase 3 astride a broken study tries to have a...

Aptadir really hopes brand new RNA preventions can turn around difficult cancers

.Italian biotech Aptadir Therapeutics has launched along with the guarantee that its own pipeline of...

Wave surfs DMD excellence to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has actually fulfilled its goal in a Duchenne muscular dystrophy (DMD) res...

Sanofi picks brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, using up the ...

Achilles splashes tissue treatment system, prepares for layoffs after skipping 'office stability' targets

.Achilles Rehabs has wrecked its own approach. The English biotech is actually stopping work on its ...

Aligos declares period 2 MASH gain, reducing liver fat up to 46%

.Aligos Therapies is actually trumpeting a midstage succeed in metabolic-dysfunction affiliated stea...